Recommendations of the German Society of Phlebology. Sclerotherapy of varicose veins: Guideline of the German Society of Phlebology;Recommandations de la Société Allemande de Phlébologie. Sclerotherapy of varicose veins: Guideline of the German Society of Phlebology

Phlebologie - Annales Vasculaires

Volumn 61, Issue 1, 2008, Pages 43-51

  Rabe, E ^a   Pannier, F ^a   Gerlach, H ^a   Breu, F X ^a   Guggenbichler, S ^a   Wolimann, J C ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952933422     PISSN: 00318280     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Alos J., Carreno P., Lopez J. A., Estadella B., Serra-Prat M., Marinel-Lo J. Efficacy and safety of sclerotherapy using Polidocanol foam: a controlled clinical trial. Eur J Vasc Endovase Surg 2006;31:101-7. (Pubitemid 43024991)
2. Baccaglini U., Spreafico G., Castoro C., Sorrentino P. Consensus Conference on Sclerotherapy or Varicose Veins of the Lower Limbs. Phlebology 1997;12:2-16. (Pubitemid 27417552)
3. Baccaglini U., Stemmer R., Partsch U. Internationale Fragebogenaktion zur Praxis der Verödungsbehandlung. Phlebologie 1997;26:129-42.
4. Barrett J. M., Allen B., Ockelford A., Goldman M. P. Microfoam ultrasoundguided sclerotherapy of varicose veins in 100 legs. Dermatol Surg 2004;20:6-12. (Pubitemid 38174021)
5. Benigni J. P. Sclérothérapie à la mousse et migraines à aura. Phlébologie 2005;58:323-4.
6. Bergan J. J., Weiss R. A., Goldman M. P. Extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 2000;26:535-42. (Pubitemid 30421443)
7. Bergan J. J., Pascarella L., Mekenas L. Venous disorders: treatment with sclerosant foam. J Cardiovasc Surg 2006;47:9-18.
8. Breu F. X., Guggenbichler S. European consensus meeting on foam sclerotherapy. April, 4-6, 2003, Tegernsee, Germany. Dermatol Surg 2004;30:709-17. (Pubitemid 38657961)
9. Breu F. X., Guggenbichler., Wollmann J. C. 2nd European Consensus Meeting on Foam Sclerotherapy, 28-30 April 2006, Tegernsee, Germany. Vow 2008;37:1-32.
10. Breu F. X., Marshall M. Sklerotherapie mit Polidocanol in einer angiologischphlebologischen Spezialpraxis. Prospektive und retrospektive Erhebung iiber Ergebnisse und Komplikationen. Phlébologie 2003;32:76-80. (Pubitemid 36775455)
11. Breu F. X., Partsch B. Reversible neurologische Komplikationen bei der Schaum-Sklerotherapie. Phlebologie 2006;3:115-6. (Pubitemid 46336867)
12. Brodersen J. P. Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter. Dermatol Surg 2007;33:469-75. (Pubitemid 46570122)
13. Bullens-Goessens Y. I. J. M., Mentink L. F., Nelemans P. J., Van Geest A. J., Veraart J. C. J. M. Ultrasound-guided sclerotherapy of the insufficient short saphenous vein. Phlebologie Germany 2004;33:89-91.
14. Cabrera J., Redondo P., Becerra A., Garrido C., Cabrera J. Jr, Garcia-Olmedo M. A., Sierra A., Lloret P., et al. Ultrasound-guided injection of Polidocanol microfoam in the management of venous leg ulcers. Arch Dermatol 2004;140:667-73. (Pubitemid 38747281)
15. Cavezzi A., Frullini A., Ricci S., Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002;17:13-8. (Pubitemid 35231053)
16. Ceulen R. P. M., Bullens-Goessens Y. I. J. M., Pi-Van De Venne S. J. A. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% Polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol Surg 2007;33:276-81. (Pubitemid 46328226)
17. Coleridge Smith P. D. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovase Surg 2006;32:577-83.
18. Conrad P., Malouf G. M., Stacey M. C. The Australian Polidocanol (Aethoxysklerol) study. Results at 2 years. Dermatol Surg 1995;21:334-6.
19. De Waard M. M., Der Kinderen D. J. Duplex ultrasonography-guided foam sclerotherapy of incompetent perforator veins in a patient with bilateral venous leg ulcers. Dermatol Surg 2005;31:580-3. (Pubitemid 43073203)
20. Darke S. G., Baker S. J. Ultrasound-guided foam sclerotherapy for the treatment of varicose veins. Br J Surg 2006;8:969-74. (Pubitemid 44214847)
21. Drake L. A., Dinehart S. M., Goltz R. W., Graham G. F., Hordinsky M. K., Lewis C. W., Pariser D. M., Skouge J. W., Webster S. B., Whitaker D. C., Butler B., Lowery B. J. Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins. J Am Acad Dermatol 1996;34:523-8. (Pubitemid 26083841)
22. Dover J., Sadick N., Goldman M. P. The role of lasers and light sources in the treatment of leg veins. Derm Surg 1999;25:328-36. (Pubitemid 29191324)
23. Duffy D. M. Cutaneous necrosis following sclerotherapy. J Anesthetic Dermatol Cosmetic Surg 1999;1, 2:157-68.
24. Einarsson E., Eklöf B., Neglén P. Sclerotherapy or surgery as treatment for varicose veins: A prospective randomized study. Phlebology 1993;8:22-6. (Pubitemid 23104620)
25. Fegan W. G. Continuous compression technique of infecting varicose veins. Lancet 1963;2:109-12.
26. Feied CF. Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states. Sem Dermatol 1993;12:135-49. (Pubitemid 23157665)
27. Feied CF., Jackson J. J., Bren T. S., Bond O. B., Fernando C. E., Young V. C., Hashemiyoon R. B. Allergic reactions to Polidocanol for vein sclerosis. J Dermatol Surg Oncol 1994;20:466-8. (Pubitemid 24356054)
28. Feuerstein W. Schwere anaphylaktische Reaktion auf Hydroxypolyaethoxydodecan. VASA 1973;3:2924.
29. Fisher D. C., Fisher E. A., Budd J. H., et al. The incidence of patent foramen ovale in 1000 consecutive patients. Chest 1995;107:1504-9.
30. Fisher D. A. Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 2000;26:1081.
31. Flückiger P. Nicht-operative retrograde Varicenverödung mit Varisylschaum. Schweiz Med Wochenschr 1956;48:1368-70.
32. Forlee M. V., Grouden M., Moore D. J., et al. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43:162-4 (Pubitemid 43083525)
33. Frullini A., Cavezzi A. Ultrasound guided sclerotherapy in the treatment of long saphenous vein insufficiency. Vasomed 1999;11:8.
34. Frullini A., Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Derm Surg 2002;28:11-5. (Pubitemid 34101573)
35. Geerts W. H., Pineo G. F., Heit J. A., Bergqvist D., et al. Prevention of Venous thromboembolism. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:338S-400S. (Pubitemid 39302602)
36. Georgiev M. Postsclerotherapy hyperpigmentations. J Dermatol Surg Oncol 1993;19:649-52.
37. Geukens J., Rabe E., Bieber T. Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol 1999;9:132-3. (Pubitemid 29158985)
38. Goldman P. M., Beaudoing D., Marley W., Lopez L, Butie A. Compression in the treatment of leg teleangiectasia: a preliminary report. J Dermatol Surg Oncol 1990:16:322-5. (Pubitemid 20159160)
39. Goldmann P. M., Bergan J. J., Guex J. J. Sclerotherapy - Treatment of varicose veins and telangiectatic leg veins, fourth Edition. Mosby Elsevier, Philadelphia 2007.
40. Goldman M. P., Sadick N. S., Weiss R. A. Cutaneous necrosis, telangiectatic matting and hyperpigmentation following Sclerotherapy. Dermatol Surg 1995;21:19-29.
41. Grondin L., Young R., Wouters L. Sclérothérapie écho-guidée et sécurité: comparaison des techniques. Phlébologie 1997;50:241-5.
42. Guex J. J. Ultrasound Guided Sclerotherapy (USGS) for perforating veins. Hawaii Med J 2000;59:261-2.
43. Guex J. J., Allaert F. A., Gillet J. L. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12, 173 sclerotherapy sessions. Dermatol Surg 2005;31:123-8.
44. Hamel-Desnos C., Desnos P., Wollmann J. C., et al. Evaluation of the efficacy of Polidocanol in the form of foam compared with liquid form in sclerotherapy of the long saphenous vein: initial results. Dermatol Surg 2003;29:1170-5. (Pubitemid 38009913)
45. Hamel-Desnos C., Ouvry P., Benigni J. P., Boitelle G., Schadeck M., Desnos P., Allaert F. A. Comparison of 1% and 3% Polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year follow-up. "The 3/1 Study". Eur J Vasc Endovase Surg 2007;34:723-9. (Pubitemid 350056378)
46. Hamel-Desnos C., Ouvry P., Desnos P., Escalard J. M., Allaert F. A. Sclérothérapie et thrombophilie: démarche pour un consensus dans la sclérothérapie chez les thrombophiles Phlébologie 2003;56:165-9.
47. Henriet J. P. One year experience with sclerotherapy of reticular veins and telangiectases using Polidocanol foam in daily Routine: feasibility results, complications. Phlébologie 1997;50:355-60.
48. Hertzman P. A., Owens R. Rapid healing of chronic venous ulcers following ultrasound-guided foam sclerotherapy. Phlebology 2007;22:34-9. (Pubitemid 46334022)
49. Hohlbaum G. Über iatrogene Schäden bei der Varizensklerosierung. in: Staubesand J., Schöpf E. (Hrsg.): Neuere Aspekte der Sklerosierungstherapie. Springer Verlag, Berlin, Heidelberg, New York, 1990:70-81.
50. Hiibner K. Ambulante Thérapie der Stammvarikose mittels Krossektomie und Sklerotherapie-ein Beitrag aus der Praxis des niedergelassenen Phlebologen. Phlebologie 1991;20:104-8.
51. Kahle B. Effizienz der Sklerosierungstherapie von Besenreisern. Eine prospektive, randomisierte, doppelblinde, placebokontroliierte Studie. Vasomed 2006;18:148.
52. Kahle B., Leng K. Efficacy of sclerotherapy in varicose veins - a prospective, blinded placebocontrolled study. Dermatol Surg 2004;30:723-8. (Pubitemid 38657963)
53. Kakkos S. K., Bountouroglou D. G., Azzam M., et al. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: Immediate results. J Endovase Ther 2006;13:357-64. (Pubitemid 44775212)
54. Kern P., Ramelet A. A., Wütschert R., et al. Single-blind, randomized study comparing Chromated Glycerin, Polidocanol solution and Polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg 2004;3:367-72. (Pubitemid 38524153)
55. Kern P., Ramelet A. A., Wiitschert R., Hayoz D. Compression after sclerotherapy for telangiectasias and reticular leg veins. A randomized controlled study. J Vas Surg 2007;45:1212-6. (Pubitemid 46817846)
56. Kersting E., Hornschuh B., Bröcker E. B. Embolia cutis medicamentosa nach Varizensklerosierung mit Polidocanol. Phlebologie 1998;27:55-7. (Pubitemid 28206576)
57. Kreussler. Fachinformationen Aethoxysklerol 0, 25%/0, 5%/l%/2% Stand 0672005, Aethoxysklerol 3%/4%, Stand 09/2005, Chemische Fabrik Kreussler & Co GmbH.
58. Künzelberger B., Pieck C., Altmeyer P., Stücker M. Migraine ophtalmique with reversible scotomas after sclerotherapy with liquid 1% Polidocanol. Derm Surg 2006;32:1410.
59. Malouf G. M. Ambulatory venous surgery versus sclerotherapy. Hawaii Med J 2000;59:248-9.
60. Massay R. A. Regarding the use of compression stockings after sclerotherapy. Dermatol Surg 1999;25:517.
61. Mayer H., Brücke H. Zur Ätiologie und Behandlung der Varizen der unteren Extremität. Chir Praxis 1957;4:521-8.
62. McCoy S., Evans A., Spurrier N. Sclerotherapy for leg telangiectasia - a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg 1999;25:381-6. (Pubitemid 29242384)
63. McDonagh B. Comments on the use of post-sclerotherapy compression. Dermatol Surg 1999;25:519-21.
64. Milleret R., Garandeau C. Sclérose des grandes veines saphènes à la mousse délivrée par cathéter écho-guidé sur veine vide: Alpha-technique - Bilan des 1000 treatments. Phlébologie 2006;59:53-8.
65. Monfreux A. Traitement sclérosant des troncs saphéniens et leurs collatérales de gros calibre par la méthode Mus. Phlébologie 1997;50:351-3.
66. Morrison N., Cavezzi A., Bergan J., Partsch H. Regarding "stroke after varicose vein foam injection sclerotherapy". J Vasc Surg 2006;44:224-5. (Pubitemid 43975286)
67. Munavalli G. S., Weiss R. A. Complications of sclerotherapy. Semin Cutan Med Surg 2007;26:22-8. (Pubitemid 46349784)
68. Myers K. A., Jolley D., Clough A., et al. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vase Endovase Surg 2007;33:116-21. (Pubitemid 44872674)
69. Norris M. J., Carlin M. C., Ratz J. L. Treatment of essential telangiectasia: effects of increasing concentrations of polidocanol. J Am Acad of Dermatol 1989;20:643-9. (Pubitemid 19091264)
70. Oesch A., Stimemann P., Mahler F. The acute ischemic syndrome of the foot after sclerotherapy of varicose veins. Schweiz Med Wochenschr 1984;114:1155-8. (Pubitemid 14055048)
71. Passariello F. Sclerosing foam and patent foramen ovale. The final report. In: Word Congress of the International Union of Phlebology; 2007 Jun. 18-20; Kyoto, Japan. Int Angiol 2007;26:87.
72. Pradalier A., Vincent D., Hentschel V., Cohen-Jonathan A. M., Daniel E. Allergie aux sclérosants des varices. Rev Fr Allergol 1995;35:440-3.
73. Rabe E. (Hrsg.): Grundlagen der Phlébologie. 3. erweiterte und vollständig überarbeitete Neuauflage, Viavital, Köln 2003.
74. Rabe E., Otto J., Schliephake D., Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised Polidocanol foam (ESAF): A randomised controlled multicentre clinical trial. Eur J Endovase Vase Surg, accepted for publication.
75. Rabe E., Pannier-Fischer F., Gerlach H., Breu F. X., et al. Guidelines for sclerotherapy of varicose veins (ICD 10:183.0, 183.1, 183.2, and 183.9). Dermatol Surg 2004;30:687-93. (Pubitemid 38657959)
76. Rao J., Wildemore J. K., Goldmann M. P. Double-blind prospective comparative trial between foamed and liquid Polidocanol and Natrium Tetradecyl Sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg 2005;31:631-5. (Pubitemid 43093412)
77. Ratanahirana H., Benigni J. P., Bousser M. G. Injection of Polidocanol foam (PF) in varicose veins as a trigger for attacks of migraine with visual aura. Cephalalgia 2003;23:850-1.
78. Reddy P., Wickers J., Terry T., Lamont P., Moller J., Dormandy J. A. What is the correct period of bandaging following sclerotherapy? Phlebology 1986;1:217-20.
79. Remy W., Vogt H. J., Borelli S. Embolia cutis medicamentosa - artige Hautnekrosen nach Sklerosierungsbehandlung. Phlebol Proktol 1978;7:67-72. (Pubitemid 9172901)
80. Sadoun S., Benigni J. P., Sica M. Étude prospective de l'efficacité de la mousse de sclérosant dans le traitement des varices tronculaires des membres inférieurs. Phlébobgie 2002;55:259-62.
81. Schadeck M. Duplex-kontrollierte Sklerosierungsbehandlung der Vena saphena magna. Phlebologie 1996;25:78-82. (Pubitemid 26290836)
82. Schadeck M., Allaert F. A. Résultats à long terme de la sclérothérapie des saphènes internes. Phlébologie 1997;50:257-62.
83. Schadeck M. Sclérose de la petite veine saphène: éviter les mauvais résultats? Phlébobgie 2004;2:165-9.
84. Schultz-Ehrenburg U., Tourbier H. Doppler-kontrollierte Verödungsbehandlung der Vena saphena magna. Phlebol u Proktol 1984;13:117-22.
85. Seydewitz V., Staubesand J. Das ultrastrukturelle Substrat der Wirkung paravasal und intraarteriell applizierter Sklerosierungsmittel: Ein experimenteller Beitrag zum Problem iatrogener Schàden nach Sklerotherapie. In: Staubesand J., Schôpf E. (Hrsg.): Neuere Aspekte der Sklerosierungstherapie. Springer, Heidelberg, 1990:40-65.
86. Sigg K. Neuere Gesichtspunkte zur Technik der Varizenbehandlung. Ther Umschau 1949;6:127-34.
87. Snow V., Qaseem A., Barry P., Hornbake E. R., et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2007;146:204-10. (Pubitemid 351650634)
88. Stanley P. R. W., Bickerton D. R., Campbell W. B. Injection sclerotherapy for varicose veins - a comparison of materials for applying local compression. Phlebology 1991;6:37-9.
89. Stücker M., Reich S., Hermes N., et al. Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with Phenprocoumon. JDDG 2006;4:734-8. (Pubitemid 44356948)
90. Tazelaar D. J., Neumann H. A. M., De Roos K. P. Long cotton wool rolls as compression enhancers in macrosclerotherapy for varicose veins. Dermatol Surg 1999;25:38-40. (Pubitemid 29242732)
91. Tessari L., Cavezzi A., Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27:58-60. (Pubitemid 32107620)
92. Van Der Plas J. P. L., Lambers J. C., Van Wersch J. W., Koehler P. J. Reversible ischaemic neurological deficit after sclerotherapy of varicose veins. Lancet 1994;343:428. (Pubitemid 24049586)
93. Villavicencio J., Pfeifer J., Lohr J., Goldman M., Cranley R., Spence R. Sclerotherapy for varicose veins: practice guidelines and sclerotherapy procedures. In: Glovicki P., Yao J. eds. Handbook of venous disorders. Chapmann & Hall Medical, London 1996:337-54.
94. Vin F. Principes de la sclérothéraphie des troncs saphènes internes. Phlébologie 1997;50:229-34.
95. Wagdi P. Migräne und offenes Foramen Ovale: nur ein vorübergehender Hoffnungsschimmer? Kardiovasc Med 2006;9:32-6.
96. Weiss R. A., Sadick N. S., Goldman M. P., Weiss M. A. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 1999;25:105-8. (Pubitemid 30195947)
97. Weiss R. A., Weiss M. A. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: Hypertonics Saline vs. Polidocanol. J Dermatol Surg Oncol 1990;16:800-4. (Pubitemid 20293587)
98. Wildenhues B. Endovenöse kathetergestiitzte Schaumsklerosierung. Phlebologie Germany 2005;34:165-70.
99. Wollmann J. C. Schaum-zwischen Vergangenheit und Zukunft. Vasomed 2002;16:34-8.
100. Wollmann J. C. The history of sclerosing foams. Dermatol Surg 2004;30:694-703.
101. ® Polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: european randomized controlled trial. Phlebology 2006;21:180-90. (Pubitemid 44913249)
102. Yamaki T., Nozaki M., Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004;30:718-22. (Pubitemid 38657962)
103. Yamaki T., Nozaki M., Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 2000;26:323-8. (Pubitemid 30207949)
104. Zipper S. G. Nervus peronäus-Schaden nach Varizensklerosierung mit Aethoxysklerol. Versicherungsmedizin 2000;4:185-7.